Comparison of Dopamine and Norepinephrine in the Treatment of Shock
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0.19 microg per kilogram per minute for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added. The primary outcome was the rate of death at 28 days after randomization; secondary end points included the number of days without need for organ support and the occurrence of adverse events. RESULTS: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine. The baseline characteristics of the groups were similar. There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42; P=0.10). However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%], P<0.001). A subgroup analysis showed that dopamine, as compared with norepinephrine, was associated with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock (P=0.03 for cardiogenic shock, P=0.19 for septic shock, and P=0.84 for hypovolemic shock, in Kaplan-Meier analyses). CONCLUSIONS: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events. (ClinicalTrials.gov number, NCT00314704.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dopamine (DA) is a neurotransmitter in the catechol family, which is often used as first-line vasoactive drug in patients with septic shock (43).”
From Dopamine Is a Siderophore-Like Iron Chelator That Promotes Salmonella enterica Serovar Typhimurium Virulence in Mice (2019) · cites this paper as [43]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Self-citationWriting Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Current Epidemiology of Septic Shock: The CUB-Réa Network
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 637
Research works printed but not linked: 1
- Mullner M, 2004, Cochrane Database Syst Rev, 3, CD003709
Cited by
Items 701–800 of 1,000
Temporary mechanical circulatory support in cardiogenic shock
Obradović, D., Freund, A., Feistritzer, H., Sulimov, D. S., Loncar, G., Abdel‐Wahab, M., Zeymer, U., Desch, S., & Thiele, H. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.11.006 · Cited by 18
A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction
Wang, J., Shen, B., Feng, X., Zhang, Z., Liu, J., & Wang, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.754303 · Cited by 18
“Some studies have also suggested using troponin to evaluate the systemic effects, etiology, and complications of CS (53).”
BackgroundMethylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study
Sari-Yavuz, S., Heck‐Swain, K., Keller, M., Magunia, H., Feng, Y., Haeberle, H. A., Wied, P., Schlensak, C., Rosenberger, P., & Koeppen, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1014276 · Cited by 18
Diagnostic et prise en charge des ischémies mésentériques aiguës
Dewitte, A., Biais, M., Coquin, J., Fleureau, C., Cassinotto, C., Ouattara, A., & Janvier, G. (2011) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2011.02.013 · Cited by 20
Norepinephrine infusion increases urine output in children under sedative and analgesic infusion
Piva, J. P., Alquati, T., Garcia, P. C. R., Fiori, H. H., Einloft, P. R., & Bruno, F. (2014) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.60.03.008 · Cited by 18
“PRISM II score 9 (4-27) 10 (4-23) 9 (4-27) 0.”
Prognosis of patients with shock receiving vasopressors
Xing, X.-Z., Wang, H., Huang, C., Yang, Q.-H., Qu, S.-N., Zhang, H., Wang, H., Gao, Y., Xiao, Q.-L., & Sun, K. (2013) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.issn.1920-8642.2013.01.011 · Cited by 18
Interrogating a clinical database to study treatment of hypotension in the critically ill
Lee, J., Kothari, R. P., Ladapo, J. A., Scott, D., & Celi, L. A. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000916 · Cited by 18
Zhou, F., & Song, Q. (2014) · Military Medical Research · doi:10.1186/2054-9369-1-6 · Cited by 18
“Recent evidence from a large-scale study revealed that there was no significant difference in the mortality rate between patients with septic shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine [4].”
BackgroundFawzy, A., Evans, S. R., & Walkey, A. J. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001149 · Cited by 18
Hiemstra, B., Koster, G., Wetterslev, J., Gluud, C. N., Jakobsen, J. C., Scheeren, T., Keus, F., & van der Horst, I. C. C. (2018) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13294 · Cited by 18
“Several randomised clinical trials (RCTs) have failed to show clinical benefits associated with use of dopamine in patients with acute heart failure5‐7 and circulatory shock.(8) Previous meta‐analyses advocate cautious use of high‐dose dopamine.”
Vasoactive Agents for Adult Septic Shock: An Update and Review
Dalimonte, M. A., DeGrado, J. R., & Anger, K. E. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019844124 · Cited by 18
“Because of its effects on the a adrenergic receptor with less emphasis on the b adrenergic receptor, norepinephrine may be more potent in reversing hypotension than dopamine while avoiding potential tachycardia.(2,24,33) There is a significant amount of pharmacokinetic variability between patients in response to norep…”
BackgroundMethodInfluentialPaediatrics: how to manage septic shock
Hon, K. E., Leung, K. K. Y., Oberender, F., & Leung, A. K. C. (2021) · Drugs in Context · doi:10.7573/dic.2021-1-5 · Cited by 18
Matalka, K. Z., Attallah, L. J., Qinna, N. A., & Alhussainy, T. M. (2011) · PubMed · Cited by 18
When Rhythm Changes Cause the Blues: New-Onset Atrial Fibrillation during Sepsis
Walkey, A. J., & McManus, D. D. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201608-1617ed · Cited by 18
Abdel‐Razek, O., Santo, P. D., Jung, R. G., Parlow, S., Motazedian, P., Prosperi‐Porta, G., Visintini, S. M., Marbach, J. A., Ramirez, F. D., Simard, T., et al. (2023) · Critical Care Explorations · doi:10.1097/cce.0000000000000962 · Cited by 17
Claudius, C., Perner, A., & Møller, M. H. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0142-z · Cited by 17
The Theory is Out There: The Use of ALPHA-2 Agonists in Treatment of Septic Shock
Ferreira, J. (2017) · Shock · doi:10.1097/shk.0000000000000979 · Cited by 17
Burguez, S. (2017) · Revista Uruguaya de Cardiología · doi:10.29277/ruc/32.3.17 · Cited by 17
“Se ha comparado el uso de la dopamina con la noradrenalina en varios pacientes con shock, y se ha sugerido que la noradrenalina podría tener menos efectos colaterales y menor mortalidad(53).”
BackgroundChen, J., Roberts, R. J., Fazzari, M. J., KASHANI, K. B., Qadir, N., Cairns, C. B., Mathews, K. S., Park, P. K., Khan, A., Gilmore, J. F., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004429 · Cited by 17
Mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock
Al‐Atta, A., Zaidan, M., Abdalwahab, A., Asswad, A. G., Egred, M., Zaman, A., & Alkhalil, M. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2302071 · Cited by 17
“Noradrenaline had lower mortality rate when compared with dopamine [30], and a better metabolic and safer profile compared to epinephrine [31,32].”
BackgroundLee, C., Kuo, G. C., Chan, M., Fan, P., Chen, J., Yen, C., Tsai, T.-Y., Chen, Y., Tian, Y., & Chang, C. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.08.022 · Cited by 17
Not all Shock States Are Created Equal
Khorsand, S., Helou, M. F., Satyapriya, V., Kopanczyk, R., & Khanna, A. K. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2022.11.002 · Cited by 17
Huang, X., Yan, W., Chen, Z., & Qian, Y. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080065 · Cited by 17
dos Santos, A. O. M. T., Furtado, E. M. D. O., Villela, N. R., & Bouskela, E. (2011) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2010-1358 · Cited by 17
Fante, C., Eldar‐Boock, A., Satchi‐Fainaro, R., Osborn, H. M. I., & Greco, F. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200382r · Cited by 17
Nagendran, M., Maruthappu, M., Gordon, A. C., & Gurusamy, K. S. (2015) · Journal of the Intensive Care Society · doi:10.1177/1751143715620203 · Cited by 17
“Both classes of drugs are associated with risks including reduction of cardiac output and regional blood flow for alpha-agonists and myocardial ischaemia with beta-agonists.(2,3) In addition to its”
BackgroundAcute Decompensated Heart Failure
Hammond, D. A., Smith, M. N., Lee, K. C., Honein, D., & Miller, A. D. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616669494 · Cited by 17
Arterial blood pressure and heart rate regulation in shock state
DellaVolpe, J. D., Moore, J. E., & Pinsky, M. R. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000239 · Cited by 17
Tubaro, M., Danchin, N., Goldstein, P., Filippatos, G. S., Hasin, Y., Heras, M., Janský, P., Norekvål, T. M., Swahn, E., Thygesen, K. A., et al. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.10.001 · Cited by 17
Comparative study of dopamine and norepinephrine in the management of septic shock
Agrawal, A., Gupta, A., Consul, S., & Shastri, P. S. (2011) · Saudi Journal of Anaesthesia · doi:10.4103/1658-354x.82784 · Cited by 17
“[2-4] Although earlier studies have shown norepinephrine to be effective,[5-7] this drug is still not widely used due to fear of excessive vasoconstriction thereby further compounding tissue hypoperfusion and leading to severe ischemia of vital organs.”
BackgroundCritical care trial design and interpretation: A primer
Sevransky, J., Checkley, W., & Martin, G. S. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eae226 · Cited by 17
Timing of norepinephrine in septic patients: NOT too little too late
Rachoin, J.-S., & Dellinger, R. P. (2014) · Critical Care · doi:10.1186/s13054-014-0691-x · Cited by 17
Zhang, F., Xue, M., Zhou, P., Tian, Y., Liu, J.-X., Dong, X., Yuan, D., Lin, Z., Zhang, L., Lin, J.-H., et al. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2264318 · Cited by 16
“in the meanwhile, the use of vasopressor, where in most cases septic shock patients are treated with norepinephrine and/or dopamine, may also induce tachyarrhythmia [28].”
BackgroundSartini, C., Landoni, G., Belletti, A., Kotani, Y., Maimeri, N., Umbrello, M., Yavorovskiy, A. G., & Jabaudon, M. (2023) · Panminerva Medica · doi:10.23736/s0031-0808.23.04986-8 · Cited by 16
Menich, B. E., Miano, T. A., Patel, G. P., & Hammond, D. A. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019843664 · Cited by 16
Transthoracic echocardiographic versus cardiometry derived indices in management of septic patients
Afandy, M. E., Sharkawy, S. I. E., & Omara, A. F. (2020) · Egyptian Journal of Anaesthesia · doi:10.1080/11101849.2020.1854597 · Cited by 16
Critical Care Management of the Patient with Pulmonary Hypertension
Mullin, C. J., & Ventetuolo, C. E. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.11.009 · Cited by 16
Recent advances in the pharmacological management of sepsis-associated acute kidney injury
Kalantari, K., & Rosner, M. H. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1978287 · Cited by 16
Suzuki, R., Uchino, S., Sasabuchi, Y., Lefor, A. K., & Sanui, M. (2022) · Critical Care · doi:10.1186/s13054-022-03960-y · Cited by 16
“It should also be noted that the patient population in the present study seemed to be less acutely ill when compared to previous cohorts such those as in the SOAP (39) or SOAP II (7) studies, where ICU mortality was about 30% in the former and the 28-day mortality was approximately 50% in the latter – while the in-hos…”
ResultA Comprehensive Appraisal of Risk Prediction Models for Cardiogenic Shock
Bhat, A. G., van Diepen, S., Katz, J. N., Islam, A. M., Tehrani, B. N., Truesdell, A. G., Kapur, N. K., Holmes, D. R., Menon, V., Jaber, W. A., et al. (2022) · Shock · doi:10.1097/shk.0000000000001921 · Cited by 16
Cagino, L. M., Moskowitz, A. L., Nallamothu, B. K., McSparron, J. I., & Iwashyna, T. J. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202205-393oc · Cited by 16
The Eight Unanswered and Answered Questions about the Use of Vasopressors in Septic Shock
Hamzaoui, O., Goury, A., & Teboul, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144589 · Cited by 17
Addison, M., Ranasinghe, P. D., & Webb, D. J. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2277330 · Cited by 16
“Taken together, these results suggest that vasopressors, norepinephrine (NE) and Ang II, which are already used to treat circulatory shock [42,43], may have pharmacological utility for urgent reversal of siRNA-mediated AGT suppression (likely in high dependency settings), whilst IV NaCl has…”
BackgroundPositive inotropes in heart failure: a review article
Amin, A., & Maleki, M. (2012) · Heart Asia · doi:10.1136/heartasia-2011-010068 · Cited by 16
“There were more arrhythmic events among the patients treated with dopamine.(20) Norepinephrine should be administered only through a central venous line because extravasation may cause tissue necrosis.”
BackgroundAssessment of adequacy of volume resuscitation
Boyd, J. H., & Sirounis, D. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000344 · Cited by 16
“Nearly 90% of patients with shock refractory to initial fluid resuscitation will require mechanical ventilation [8,9].”
BackgroundChenprakhon, P., Dhammaraj, T., Chantiwas, R., & Chaiyen, P. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.03.004 · Cited by 16
Choque cardiogénico: de la definición al abordaje
Garnica-Camacho, C. E., Sigarroa, E. R., & Domínguez‐Cherit, G. (2019) · Medicina Crítica · doi:10.35366/89525 · Cited by 16
Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art
Hajjar, L. A., & Teboul, J. (2019) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-06067-1_13 · Cited by 16
Lam, S., Lau, A. C., Lam, R. P. K., & Yan, W. (2017) · Hong Kong Medical Journal · doi:10.12809/hkmj165057 · Cited by 16
Therapeutic Approach to the Critically Poisoned Patient
Schwarz, E. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-17900-1_63 · Cited by 15
The role of invasive techniques in cardiopulmonary evaluation
Backer, D. D., Fagnoul, D., & Herpain, A. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283609194 · Cited by 15
“Shock is associated with mortality rates around 50% [1,2], but these are markedly influenced by the disease process leading to shock.”
BackgroundInotropes in acute heart failure
Bistola, V., & Chioncel, O. D. (2017) · Continuing Cardiology Education · doi:10.1002/cce2.59 · Cited by 15
“In a recent trial comparing norepinephrine to dopamine in cardiogenic and non-cardiogenic shock, norepinephrine was similarly efficacious in terms of 28 days mortality albeit safer than dopamine, which was associated with higher rates of arrhythmic adverse events and higher mortality in the subgroup of cardiogenic sho…”
BackgroundShort-term treatments for acute cardiac care: inotropes and inodilators
Guarracino, F., Zima, E., Pollesello, P., & Masip, J. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa090 · Cited by 15
“When vasopressors are used to support blood pressure, noradrenaline should be preferred to adrenaline, based on the findings of the OPTIMA-CC trial, in which adrenaline induced excessive refractory heart failure,(25) and findings from the SOAP-II trial.(26) Although no definitive randomized trials have been conducted…”
MethodEffect of methylene blue on hemodynamic and metabolic response in septic shock patients
Luis-Silva, F., Menegüeti, M. G., Sepeda, C. D. R., Petroski-Moraes, B. C., Sato, L., Peres, L. M., Becari, C., Basile-Filho, A., Evora, P. R. B., Martins‐Filho, O. A., et al. (2022) · Medicine · doi:10.1097/md.0000000000028599 · Cited by 15
Priyanka, P., Chang, C.-C. H., Chawla, L. S., Kellum, J. A., Clermont, G., & Murugan, R. (2022) · Shock · doi:10.1097/shk.0000000000001980 · Cited by 15
“However, no vasopressor has been shown to be superior to norepinephrine for lowering the risk of death (1,12,13).”
BackgroundResultInflammatory response in sepsis and hemorrhagic stroke
Jelinek, M., & Ďuriš, K. (2022) · Brain Hemorrhages · doi:10.1016/j.hest.2022.10.005 · Cited by 15
Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock
Na, S. J., Yang, J. H., Ko, R., Chung, C. R., Cho, Y. H., Choi, K. H., Kim, D., Park, T. K., Lee, J. M., Song, Y. B., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277087 · Cited by 15
“Given that about 20% of patients in the SOAP II trial died from refractory shock, we cannot rule out the possibility that the use of mechanical circulatory support devices influenced the results of our study [16].”
MethodManagement of Post–Myocardial Infarction Right Ventricular Failure
Haloot, J., Mahmoud, M., Prasad, A., Anderson, A. S., & Aslam, M. I. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100526 · Cited by 15
Chander, S., Kumari, R., Sadarat, F., & Luhana, S. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101805 · Cited by 16
Sugiura, M., Mitaka, C., Haraguchi, G., Tomita, M., & Inase, N. (2015) · Journal of Intensive Care · doi:10.1186/s40560-015-0080-9 · Cited by 15
“Dopamine and norepinephrine have been used as vasopressor therapy to restore and maintain blood pressure, although the use of dopamine was associated with a greater number of adverse events [16].”
MethodSantamaria, M. H., Aletti, F. M., Li, J. B., Tan, A., Chang, M., Leon, J., Schmid‐Schönbein, G. W., & Kistler, E. B. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001513 · Cited by 15
Recognition and Treatment of Sepsis in Pregnancy
Kendle, A. M., & Louis, J. M. (2018) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12740 · Cited by 15
Update of Sepsis: Recent Evidences about Early Goal Directed Therapy
Cho, W. H. (2015) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2015.78.3.156 · Cited by 15
Akute und chronische Herzinsuffizienz
Kresoja, K., Schmidt, G., Kherad, B., Krackhardt, F., Spillmann, F., & Tschöpe, C. (2017) · Herz · doi:10.1007/s00059-017-4613-y · Cited by 15
“Dopamin stellt nur eine Alternative beim hypovolämischen oder septischen Schock dar [43].”
Treating Shock — Old Drugs, New Ideas
Levy, J. H. (2010) · New England Journal of Medicine · doi:10.1056/nejme1000091 · Cited by 15
Sheehan, M. M., Sokoloff, L. J., & Reza, N. (2024) · Cardiology Clinics · doi:10.1016/j.ccl.2024.02.005 · Cited by 14
Outcomes and Management of Stressor-Associated Atrial Fibrillation
Haimovich, J. S., Kany, S., Ajufo, E. C., Andrade, J. G., Benjamin, E. J., Healey, J. S., Kirchhof, P. F., Lubitz, S. A., McIntyre, W. F., Rienstra, M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.031 · Cited by 14
2025 Clinical practice guidelines for Myocarditises
Arutyunov, G. P., Драгунов, Д. О., Жиров, И. В., Моисеева, О. М., Палеев, Ф. Н., Sokolova, A. V., Apkhanova, T. V., Arutyunov, A. G., Blagova, O. V., Габрусенко, С. А., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6458 · Cited by 14
The cardiorenal syndrome: a mutual approach to concomitant cardiac and renal failure.
Ben‐Shoshan, J., Entin‐Meer, M., Guzner‐Gur, H., & Keren, G. (2012) · PubMed · Cited by 14
Pharmacological Management of Cardiorenal Syndromes
House, A. A., Haapio, M., Lassus, J. P. E., Bellomo, R., & Ronco, C. (2011) · International Journal of Nephrology · doi:10.4061/2011/630809 · Cited by 14
Consenso para la mejora de la atención integral de los pacientes con insuficiencia cardíaca aguda
Delgado, J. F., Cepeda, J. M., Llorens, P., Jacob, J., Colet, J. C., Montero, M., Miró, Ò., de Sá, E. L., Manzano, L., Martín‐Sánchez, F. J., et al. (2021) · Revista Clínica Española · doi:10.1016/j.rce.2020.12.001 · Cited by 14
Cardiopulmonary Resuscitation and Critical Care After Cardiac Arrest
Jentzer, J. C., & Callaway, C. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52993-8.00051-5 · Cited by 14
Biomarkers in cardiogenic shock
Lassus, J. P. E., Tarvasmäki, T., & Tolppanen, H. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.03.002 · Cited by 14
Evaluation and management of emergencies in the patient with cirrhosis
Velasco, J. A. V.-R., García-Jiménez, E. S., Aldana-Ledesma, J. M., Tapia-Calderón, D. K., Tornel-Avelar, A. I., Lazcano-Becerra, M., Chávez-Ramírez, R. M., Cano-Contreras, A. D., Remes-Troche, J. M., Colunga‐Lozano, L. E., et al. (2022) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2022.05.001 · Cited by 14
Management of the acute on chronic liver failure in the intensive care unit
Karvellas, C. J., Gustot, T., & Fernández, J. (2023) · Liver International · doi:10.1111/liv.15659 · Cited by 15
Distinct host-response signatures in circulatory shock: a narrative review
Soussi, S., dos Santos, C. C., Jentzer, J. C., Mebazaa, A., Gayat, É., Pöss, J., Schaubroeck, H., Billia, F., Marshall, J. C., & Lawler, P. R. (2023) · Intensive Care Medicine Experimental · doi:10.1186/s40635-023-00531-5 · Cited by 14
Samarin, M. J., Mohrien, K. M., & Oliphant, C. S. (2015) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000082 · Cited by 14
Kanchi, M., D, M. R., Maessen, J. G., Vincent, L., & Belani, K. G. (2017) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_48_17 · Cited by 14
Update in the Management of Acute Coronary Syndrome Patients with Cardiogenic Shock
Bagai, J., & Brilakis, E. S. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1102-3 · Cited by 14
Vipani, A., Lindenmeyer, C. C., & Sundaram, V. (2021) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001568 · Cited by 14
Evolving Presentation of Cardiogenic Shock: A Review of the Medical Literature and Current Practices
Olarte, N., Rivera, N. T., & Grazette, L. P. (2022) · Cardiology and Therapy · doi:10.1007/s40119-022-00274-6 · Cited by 14
“From the SOAP II trial (Sepsis Occurrence in Acutely Ill Patients), a pre-specified subgroup analysis of CS patients demonstrated norepinephrine in comparison to dopamine, was associated with improved survival and fewer arrhythmias [3, 28, 29].”
ResultBerg, R. M. G., Plovsing, R. R., Bailey, D. M., Holstein‐Rathlou, N., & Møller, K. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12421 · Cited by 14
Hemodynamic management of septic shock.
Lipcsey, M., Castegren, M., & Bellomo, R. (2015) · PubMed · Cited by 14
Cardiovascular Management of Septic Shock in 2012
Guillamet, C. V., Rhee, C., & Patterson, A. J. (2012) · Current Infectious Disease Reports · doi:10.1007/s11908-012-0279-z · Cited by 14
“12 %) [84].”
Understanding Vasoactive Medications: Focus on Pharmacology and Effective Titration
Allen, J. M. (2014) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000022 · Cited by 14
Evaluación y tratamiento del paciente cirrótico crítico
Fernández, J., Aracil, C., Solà, E., Soriano, G., Cardona, M. C., Coll, S., Genescà, J., Hombrados, M., Morillas, R. M., Martín–Llahí, M., et al. (2016) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2015.09.019 · Cited by 14
Zimmerman, J. M., & Cahalan, M. K. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1679-5.00022-3 · Cited by 14
Kim, H. Y., Lee, J. E., Ko, J. S., Gwak, M. S., Lee, S., & Kim, G. S. (2018) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2018.95.1.45 · Cited by 14
Cioccari, L., Zante, B., Bloch, A., Berger, D., Limacher, A., Jakob, S. M., Takala, J. A., & Merz, T. M. (2018) · Trials · doi:10.1186/s13063-018-2714-4 · Cited by 14
Vasopressors in shock: are we meeting our target and do we really understand what we are aiming at?
Dünser, M. W., Hjortrup, P. B., & Pettilä, V. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4269-8 · Cited by 14
Non-invasive hemodynamic monitoring by electrical impedance tomography
Proença, M. (2017) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.5075/epfl-thesis-7444 · Cited by 14
“Both hypovolemic and cardiogenic accounted for 16 % of all cases, and obstructive shock for 2 % [39, 169].”
BackgroundAntonucci, E., Garcia, B., & Legrand, M. M. (2024) · Anesthesiology · doi:10.1097/aln.0000000000004958 · Cited by 13
Point of care ultrasound for monitoring and resuscitation in patients with shock
Martínez, Á. R., Luordo, D., Rodríguez-Moreno, J., Esteban, A. D. P., & Arrese, M. T. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03898-3 · Cited by 13
“According to the European Sepsis Occurrence in Acutely Ill Patients II (SOAP II) trial, the types of shock include obstructive (2%), cardiogenic (17%), distributive (62%), and hypovolemic (16%), which often overlap [1].”
Moon, Y., Kim, S., Park, Y., Kim, J.-M., & Hwang, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050715 · Cited by 13
Optimal norepinephrine-equivalent dose to initiate epinephrine in patients with septic shock
Ammar, M. A., Limberg, E., Lam, S. W., Ammar, A. A., Sacha, G. L., Reddy, A. J., & Bauer, S. R. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.05.024 · Cited by 13
Mechanical Circulatory Support for Acute Heart Failure Complicated by Cardiogenic Shock
Choi, M. S., Shim, H., & Cho, Y. H. (2020) · International Journal of Heart Failure · doi:10.36628/ijhf.2019.0015 · Cited by 13
Andrei, S., Nguyen, M., Arab, O. A., Bouhemad, B., & Guinot, P. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.818386 · Cited by 13
“Overall Pressure responder Pressure non-responder 3 [1;8] 2 [0;8] 5 [1;8] NA NA NA 9 [4;14] 10 [3;18] 9 [4;13]”
A Standardized Step-by-Step Approach for the Diagnosis and Treatment of Sepsis
Gao, Y., Wang, H., Zhang, Z. J., Pan, C. K., Wang, Y., Zhu, Y. C., Xie, F. J., Han, Q. Y., Zheng, J., Dai, Q. Q., et al. (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221085181 · Cited by 13
“At present, norepinephrine is recommended as the first-line vasopressor for septic shock patients, owing to its fewer adverse reactions compared with other vasopressors.(48,49) However, it is not highly appropriate for all septic shock patients with different hemodynamic statuses.”
BackgroundCHANGES IN VASOACTIVE DRUG REQUIREMENTS AND MORTALITY IN CARDIAC INTENSIVE CARE UNIT PATIENTS
Jentzer, J. C., Patel, P. C., van Diepen, S., Morrow, D. A., Barsness, G. W., & KASHANI, K. B. (2023) · Shock · doi:10.1097/shk.0000000000002123 · Cited by 13
“We did not directly examine the prognosis associated with the use of specific vasoactive drugs, recognizing that prior analyses have suggested better outcomes with the use of norepinephrine in CS (11,12,36,37).”
Result
Metadata
- Authors
- De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L.
- Affiliations
- Université Libre de Bruxelles (BE)
- Medical University of Vienna (AT)
- Centre hospitalier Etterbeek-Ixelles (BE)
- Erasmus Hospital (BE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-03-04
- Volume
- 362
- Issue
- 9
- Pages
- 779-789
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095944485
- Cited by
- 1,940
- References
- 31
- Citations by year
- 2026: 98 · 2025: 107 · 2024: 140 · 2023: 115 · 2022: 125 · 2021: 132 · 2020: 135 · 2019: 138 · 2018: 106 · 2017: 139 · 2016: 99 · 2015: 122 · 2014: 120 · 2013: 96 · 2012: 110
- FWCI
- 83.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- dopamine, norepinephrine, vasopressors, shock, cardiogenic shock, septic shock, hypovolemic shock, 28-day mortality, cardiac arrhythmias, epinephrine, vasopressin, organ support, adverse events, subgroup analysis, vasopressor weaning
- MeSH terms
- Aged, Arrhythmias, Cardiac, Combined Modality Therapy, Dopamine, Female, Fluid Therapy, Humans, Male, Middle Aged, Norepinephrine, Shock, Vasoconstrictor Agents, Kaplan-Meier Estimate, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.